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Full differentiation potential along with self-renewal capacity is a major property 
of pluripotent stem cells (PSCs). However, the differentiation capacity frequently 
decreases during expansion of PSCs in vitro. We show here that transient exposure 
to a single microRNA, expressed at early stages during normal development, 
improves the differentiation capacity of already-established murine and human 
PSCs. Short exposure to miR-203 in PSCs (miPSCs) induces a transient expression 
of 2C-markers that later results in expanded differentiation potency to multiple 
lineages, as well as improved efficiency in stringent assays such as tetraploid 
complementation and human-mouse interspecies chimerism. Mechanistically, 
these effects are at least partially mediated by direct repression of de novo DNA 
methyltransferases Dnmt3a and Dnmt3b, leading to transient and reversible 
erasing of DNA methylation. These data support the use of transient exposure to 
miR-203 as a general and single method to reset the epigenetic memory in PSCs, 
and improve their effectiveness in regenerative medicine. 
 






Pluripotent stem cells (PSCs) provide an important promise for regenerative medicine 
due to their self-renewal potential and ability to differentiate into multiple cell lineages. 
During the last years, multiple efforts have been put into improving the potential of 
these cells either by expanding their differentiation capacity into a wider variety of cell 
lineages or by improving maturation properties into specific functional cell types (Li & 
Izpisua Belmonte, 2016, Takahashi & Yamanaka, 2016). PSCs are commonly cultured 
in the presence of Mek1/2 and Gsk3 inhibitors together with the cytokine Lif (2i/L 
conditions (Ying, Wray et al., 2008)). Although these conditions may improve the 
maintenance of pluripotency in vitro, recent evidences suggest that prolonged inhibition 
of Mek1/2 may limit the developmental and differentiation capacity of PSCs in vivo, in 
part by inducing irreversible demethylation of imprinting control regions (ICRs)(Choi, 
Huebner et al., 2017a, Yagi, Kishigami et al., 2017). Recent data suggest that genetic 
ablation of miR-34 in PSCs results in improved potential to form embryonic and 
extraembryonic tissues in part by promoting Gata2 expression (Choi, Lin et al., 2017b), 
although the conditions for applying this information to favor the differentiation 
potential of PSCs remain to be established. Finally, a recent alternative proposal 
suggests the use of a chemical cocktail of inhibitors that also enhances the 
developmental potential of PSCs (Yang, Liu et al., 2017); however, the applicability of 
this method is still limited due to the lack of mechanistic details.  
 Here, we identified miR-203 as a microRNA preferentially expressed in the 2C-
morula stages during preimplantation development in the mouse embryo. By using a 
variety of in vitro and in vivo approaches, we report that transient exposure of already-
established induced pluripotent stem cells (iPSC) or ESCs to miR-203 enhances the 
ability of these PSCs to differentiate into multiple cell lineages and to reach further 
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maturation properties. Transient expression of miR-203 in PSCs (miPSCs) leads to 
greater developmental potential in tetraploid complementation assays, and significantly 
improves the efficiency of human iPSCs in contributing to interspecies human-mouse 
conceptuses. Mechanistically, these effects are at least partially mediated through the 
miR-203-dependent control of de novo DNA methyltransferases Dnmt3a and Dnmt3b, 
thereby regulating the DNA methylation landscape of these miPSCs. These observations 
suggest that the developmental and differentiation potential of already established PSCs 
can be readily enhanced by transient exposure to a single microRNA. 
 
RESULTS 
miR-203 improves the differentiation potency of PSCs 
miR-203 was originally proposed to limit the stemness potential of skin progenitors (Yi, 
Poy et al., 2008) and to display tumor suppressive functions in multiple cancers (Bueno, 
Perez de Castro et al., 2008, Michel & Malumbres, 2013), suggesting a role in the 
balance between stemness and differentiation. However, its expression during early 
development remained undefined. A first analysis of miR-203 levels during normal 
murine and bovine development suggested a modest but specific wave of expression 
during early development (blastocysts stage in murine and more particularly hatched 
blastocysts in bovine embryos), whereas its expression was lost in cultured embryonic 
stem cells (Goossens, Mestdagh et al., 2013, Yang, Bai et al., 2008). Interestingly, our 
quantitative PCR analysis in mouse embryos isolated at different early developmental 
stages showed that miR-203 expression was low in oocytes, slightly induced at the 2-
cell stage and displayed a gradual reduction in morulas and blastocysts (Fig. 1A).   
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 To easily manipulating miR-203 levels in vitro and in vivo, we generated a 
tetracycline-inducible knock-in model in which the miR-203-encoding sequence was 
inserted downstream of the type I collagen gene and expressed under the control of a 
tetracycline-responsive element [ColA1(miR-203) allele] in the presence of tetracycline 
reverse transactivator expressed from the Rosa26 locus [Rosa26(rtTA) allele] (Fig. 
EV1A). Treatment of ColA1(miR-203/miR-203); Rosa26(rtTA/rtTA) mouse embryonic 
fibroblasts (MEFs) or ESCs with doxycycline (Dox) led to a significant induction of 
miR-203 levels (Fig. EV1B). We also generated iPSCs from wild-type or un-induced 
ColA1(miR-203/miR-203); Rosa26(rtTA/rtTA) MEFs by using lentiviral vectors 
expressing Oct4, Sox2, Klf4 and cMyc (Takahashi & Yamanaka, 2006). Similar to 
MEFs or ESCs, these mutant iPSCs showed a significant induction of miR-203 after 
treatment with doxycycline (Fig. EV1B). Although previous reports have suggested that 
this system suffers of relative leakiness (Stadtfeld, Maherali et al., 2010), miR-203 
expression significantly reduced and was undetectable a few days after Dox withdrawal 
(Fig. EV1C). 
We next studied the long-term effects of miR-203 by treating ColA1(miR-
203/miR-203); Rosa26(rtTA/rtTA) iPSCs (generated in the absence of Dox) transiently 
with Dox for 5 days (microRNA-transiently induced iPSCs or miiPSCs; Fig. 1B). RNA 
sequencing of these iPSC clones as well as wild-type ESCs was analyzed ten days or 
one month after miR-203 induction (Fig. 1B) and surprisingly revealed that miiPSCs 
cells were transcriptionally closer to ESCs than Dox-treated wild-type iPSCs both at the 
genome-wide level (Fig. 1C) and when considering a pluripotency-associated signature 
defined previously (Chung, Lin et al., 2012) (Fig. EV1D). In addition, almost every 
transcript included in a 282-gene signature of 2C blastomeres (Biase, Cao et al., 2014) 
was induced by miR-203 and sustained during ten days after Dox withdrawal (Fig. 1D 
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and EV1E), including genes such as Zscan4c previously related to the zygotic 
transcriptional program (Eckersley-Maslin, Alda-Catalinas et al., 2019). Importantly, 
we also assessed the transcriptomes of different clones of miiPSCs, mESCs, 2-cell-like 
mESCs subpopulations (MacFarlan et al., 2012; GSE 33923) and epiblast stem cells 
(Najm et al., 2011; GSE 26814) (Fig. 1B, E). Principal Component Analysis revealed a 
gene expression pattern of miiPSCs clones 1 and 2 (analyzed 10 days after miR-203 
exposure) similar to that observed for Tomato-positive cells, characterized as 2C-like 
ESCs by MacFarlan and collaborators, while miiPSCs clones 3 and 4 (analyzed 25 days 
after miR-203 exposure) exhibited a profile more similar to ESCs clones, corroborating 
the observations showed in Fig. 1D. An additional comparison of the expression 
profiles in miiPSCs versus un-induced iPSCs at day 30 after doxycycline withdrawal 
suggested higher expression of genes related to tissue morphogenesis and embryonic 
development in those clones in which miR-203 had been transiently induced (Fig. 1B, 
EV1F and Dataset EV1).  
The differentiation potential of miiPSCs was directly tested in the embryoid 
body (EB) formation assay in vitro. Transient induction of miR-203 for 5 days followed 
by 2-4 weeks of Dox withdrawal in either iPSCs (miiPSCs) or ESCs (miESCs) resulted 
in a significant increase in EB size accompanied by the formation of large internal 
cavities (Fig. 1F, G and Appendix Figure S1A-C). Furthermore, miiPSC- and miESC-
derived EBs showed beating with higher efficiency and at earlier time points than their 
untreated counterparts (Fig. 1G and Appendix Figure S1C). miiPSC-derived EBs 
displayed a complex organization with high expression of primitive endoderm (Gata4), 
mesoderm (Cd34) and ectoderm (Pax6) or neuroectoderm (Nestin) markers (Appendix 
Figure S1D-E and Movie EV1).  
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To further validate these observations beyond the genetic model, we tested the 
effect of transient expression of ectopic miR-203 using a CMV-driven retroviral vector 
or RNA mimics (Fig. EV1G and Appendix Figure S1F-G). These two strategies also 
resulted in improved EB formation (large cavities, beating) in miiPSCs or miESCs (Fig. 
EV1G), indicating that these effects were not unique to the inducible genetic model.  
Since the combination of the MEK inhibitor PD0325901 and the GSK3 inhibitor 
CHIR99021 with LIF (2i/L conditions) has been previously shown to render iPSCs 
closer to ESCs (Ying et al., 2008), we also tested the effect of miR-203 under 2i/L 
conditions. miiPSCs grown in 2i/L also displayed an enrichment in the transcription of 
stemness factors and developmental pathways when compared to wild-type iPSCs 
grown in the same conditions (Appendix Figure S2A). In addition, pre-treatment with 
Dox for 5 days, 2-4 weeks prior to EB assays, of miiPSCs cultured in 2i/L conditions 
promoted a significant increase in EB size, formation of large internal cavities as well as 
beating (Appendix Figure S2B-C), suggesting an additional effect of miR-203 over the 
2i/L conditions.   
The expression of miR-203 at the 2-cell stage inspired us to further analyze the 
early expression of 2C- related endogenous retroviruses in cultured miPSCs. Transient 
expression of miR-203-GFP in wild-type ES cells significantly increased the number of 
2C-like cells as determined by the expression of the murine endogenous retrovirus with 
leucine tRNA primer (MuERV-L; 2C::tdTomato reporter; Macfarlan et al., 2012) 
analyzed 24 hours after miR-203 addition (Appendix Figure S3A). In line with these 
observations, exposure to miR-203 induced the primary expression of genes harboring a 
proximal upstream or an intronic MERVL element (Appendix Figure S3B).  
Of interest, transient exposure to miR-203 mimics also rendered human 
pluripotent cells to a ground naive state (Appendix Figure S3C-D), as measured by the 
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expression of the family HERVH of human endogenous retroviruses (HERVs) involved 
in the maintenance of human naive pluripotency (Wang et al., 2016). miR-203 mimics 
induced the expression of the HERVH-GFP reporter in a significant number of colonies, 
in many cases not only in the periphery but in almost the totality of the cells of the 
colony, and such expression was sustained for 5 days in culture. When the 
differentiation potential of these cultures was tested (several weeks after miR-203 
transient expression), human miiPSCs generated significantly bigger EBs with larger 
internal cavities than the control counterparts (Fig. 1H, I), suggesting altogether that the 
effect of miR-203 can be achieved using delivery systems with independence of the 
genetic knock-in system and it is also functional in human cells.  
miR-203 expands developmental potential and plasticity of PSCs 
We then tested the potential of miiPSCs (in which the expression of miR-203 had only 
been induced for 5 days in vitro) to form teratomas either after subcutaneous or 
intraperitoneal injection. miiPSCs formed significantly bigger tumors in these assays 
(Fig. 2A). Intriguingly, these teratomas were not only bigger but they contained tissues 
that are not typically found in control iPSC-induced teratomas, such as bone marrow, 
pancreas or cartilage, as well as trophoblast giant cells as confirmed by the expression 
of PL-1 (Fig. 2B and Fig. EV2). Transcriptomic studies in these complex structures 
suggested upregulation of genes involved in embryonic development and organ 
morphogenesis when derived from miiPSCs (Appendix Figure S4A and Appendix 
Table S1). Immunohistochemistry studies showed elevated expression of multiple 
differentiation markers representing ectoderm, mesoderm and endoderm in miiPSC-
derived teratomas (Appendix Figure S4B, C). Interestingly, these teratomas also showed 
elevated levels of proliferation (as scored by Ki67; Appendix Figure S4D) or 
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pluripotency markers such as Nanog, Oct4 or Sox2 in vivo (Appendix Figure S4B), 
suggesting that these structures contained a complex mixture of undifferentiated cells, 
expressing stemness markers, together with differentiated cells.  
It has been reported that iPSCs generated in vivo are able to form small embryo-
like structures, containing tissues derived from the three germinal layers in the presence 
of extraembryonic membranes, when inoculated intraperitoneally (Abad, Mosteiro et 
al., 2013). In our hands, wild-type iPSCs generated in vivo were able to form embryo-
like structures in 11% of injected mice, with an efficiency similar to the one reported 
previously (Abad et al., 2013). However, miiPSCs generated in vitro were much more 
efficient, with 83% of injected mice showing embryo-like structures (Fig. 2C). As in the 
case of in vivo-formed iPSCs, miiPSC embryo-like structures were positive for specific 
markers of the three embryonic layers (Fig. 2D). Brief exposure to miR-203 in vitro also 
improved the formation of chimeras both from miiPSCs and miESCs, achieving 100% 
of chimerism efficiency in miESCs (19 chimeras were obtained out of 19 pups born; 
Appendix Figure S5). The number of chimeras that reached adulthood and contributed 
to germline transmission was also notably increased (5 to 10 times, respectively) in 
miiPSC- and miESC-derived mice compared to their respective untreated controls. 
 The performance of miiPSCs was also tested in the tetraploid complementation 
assay, one of the most stringent tests for developmental potency. Few iPSCs are 
efficient in this assay in which any born animal develops uniquely at the expense of 
exogenous diploid iPSCs (or ESCs) incorporated into a tetraploid embryo. Whereas we 
did not obtain all-iPSC mice in control iPSCs, the very same clones were able to form 
all-miiPSC mice after transient in vitro exposure to miR-203 (Fig. 2E). Importantly, half 
(2/4) of these “all-miiPSC” mice reached adulthood healthy and were proficient for 
germline transmission (Fig. 2E). Although specific clones of iPSCs have been 
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previously found to contribute to all-iPSC mice (Li, Zhang et al., 2011), it is important 
to consider that the effect of miR-203 is additive on already-established PSCs providing 
an easy protocol for enhancing available PSCs. 
miR-203 increases human-mouse interspecies chimera competency  
The high efficiency of miPSCs in contributing to mouse chimeras led us to test their 
effect in the formation of interspecies human-mouse conceptuses. Td-Tomato 
fluorescent-labeled human iPSCs were transiently transfected with pMCSV-miR-203-
GFP (human miiPSCs) and cells were maintained at least one week in culture to ensure 
that miR-203 expression was transient and absent before cell injection. To compare the 
effect of miR-203 in the context of the most efficient protocol reported so far, we 
cultured these human cells in the presence of human LIF, CHIR99021, (S)-(+)-
Dimethindene maleate and Minocycline hydrochloride (LCDM), a cocktail recently 
proposed to enhance the potential of PSCs (Yang et al., 2017). We initially injected 15 
human iPSCs into 8C-stage mouse embryos and examined its chimeric contribution 
after 48–60 h of culture in vitro. As shown in Appendix Figure S6, pre-exposure of 
human miiPSCs to miR-203 resulted in 100% of the mouse blastocysts presenting Td-
Tomato-positive human cells (also identified with anti-human OCT4 antibodies), 
whereas this efficiency was only 60% when using control human iPSCs. We next 
examined the contribution of human iPSCs to interspecies chimeras in similar assays in 
which injected 8C-stage embryos were allowed to implant (Appendix Figure S7). The 
presence of human cells in mouse E10.5 conceptuses was identified by immunostaining 
with anti-human nuclei (HuNu) antibody or by direct detection of fluorescent Td-
Tomato. Both HuNu and Td-Tomato positive areas were significantly increased in 
embryos injected with miiPSCs when compared to control iPSCs (Appendix Figure S7), 
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suggesting a more efficient contribution of human iPSCs to mouse embryos after brief 
exposure to miR-203. 
To further challenge the system, we injected one single human iPSCs into 8C-
stage mouse embryos and examined its chimeric contribution after 48–60 h of culture in 
vitro. As shown in Fig. 3A, B pre-exposure of human miiPSCs to miR-203 resulted in 
80-100% of the mouse blastocysts presenting Td-Tomato-positive human cells (also 
identified with anti-human OCT4 and HuNu antibodies), whereas this efficiency was 
only 54% when using control human iPSCs also cultured in the presence of LCDM but 
not miR-203. We next examined the contribution of human iPSCs to interspecies 
chimeras in similar assays in which one-human-cell injected 8C-stage embryos were 
allowed to implant. The presence of human cells in mouse E9.5 conceptuses was 
identified by immunostaining with anti-human nuclei (HuNu) antibody or by direct 
detection of fluorescent Td-Tomato, and their proper integration and differentiation into 
the mouse embryo was corroborated using embryo markers such as Gata4, Sox2 or 
hSOX17 (Fig. EV3C). Both HuNu and Td-Tomato positive areas were significantly 
increased in embryos injected with miiPSCs when compared to control iPSCs (Fig. 3C-
E and Fig. EV3A, B). Altogether, these data suggested a more efficient contribution of 
human iPSCs to mouse embryos after brief exposure to miR-203. 
miR-203 effects are Dnmt3a/b-dependent 
To analyze the mechanism by which miR-203 enhances the differentiation capacity of 
PSCs, we searched for predicted miR-203 targets among the transcripts downregulated 
in miiPSCs (Fig. 4A). As the long-term effects resulting from transient expression of 
miR-203 suggest an epigenetic mechanism, we selected from the previous list those 
genes involved in epigenetic regulation of gene expression (GO0040029). We found 18 
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GO0040029 transcripts downregulated in miiPSCs cells and predicted as miR-203 
targets according to different microRNA target prediction algorithms (Fig. 4A and 
Appendix Table S2). Among these transcripts, the top hits with the highest score as 
miR-203 targets corresponded to the de novo DNA methyltransferases Dnmt3a and 
Dnmt3b. These two transcripts were also significantly downregulated after expression 
of miR-203 mimics in wild-type iPSCs (log2 fold change= −0.24 for Dnmt3a and −0.22 
for Dnmt3b transcripts). Human miR-203 and DNMT3a/b transcripts have been 
previously shown to display inverse expression profiles in cancer cells (Gasque Schoof, 
Izzotti et al., 2015, Sandhu, Rivenbark et al., 2012) and DNMT3b was recently shown to 
be a direct miR-203 target in human colon cancer cells(To, Leung et al., 2017). Both 
Dnmt3a and Dnmt3b transcripts contain conserved miR-203 sites in their 3’-UTR (Fig. 
EV4A) and exogenous expression of miR-203 led to decreased signal of a luciferase 
construct fused to these sequences, but not to 3’-UTR sequences from the related genes 
Dnmt3l or Dnmt1 (Fig. 4B, C). The downregulation of these genes was abrogated (Fig. 
4C) when the putative miR-203 binding sites were mutated (Fig. EV4B) indicating a 
direct control of these transcripts by miR-203. To further confirm the regulation of 
DNMT3A/B by miR-203, we also tested their protein levels in 5 different clones of 
mouse un-induced iPSCs or miiPSCs as well as one human cell line, transfected with 
control or miR-203 mimics, immediately after miR-203 exposure (Fig. EV4E).  
To test to what extent downregulation of Dnmt3a/b could mimic the effect of 
miR-203 we knocked down these de novo DNA methyltransferases by RNA 
interference means (siDnmt3a/b). RNA sequencing of these samples (following the 
protocols explained above) revealed that siDnmt3a/b iPSCs exhibited a transcriptomic 
profile closer to miiPSCs (Fig. 4D and EV4C). In addition, downregulation of Dnmt3a/b 
induced the growth, formation of long cavities and increased beating of EBs to a similar 
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extent to that observed in miiPSC-derived EBs (Fig. 4E, F), whereas individual 
knockdown of these transcripts displayed partial effects (Fig. 4E, F and EV4D). 
Importantly, overexpression of miR-203-resistant Dnmt3a and Dnmt3b cDNAs, 
simultaneously to the transient doxycycline treatment, prevented the overgrowth of 
miiPSC-derived EBs (Fig. 4G, H and EV4D).  
At shorter time points, knockdown of Dnmt3a/b also increased the 2C-like 
population in wild-type ESCs as scored by the expression of the MERVL element 
(Appendix Figure S8), although to lesser extent than miR-203. Whether these 
differences are due to variable efficiencies in the control of gene expression of 
additional miR-203 targets is unclear at present. Moreover, expression of miR-203-
resistant Dnmt3a/b cDNAs significantly prevented the expression of the 2C-related 
marker, as measured five days after transfections (Appendix Figure S8). Altogether, 
these observations demonstrate that Dnmt3a/b de novo methyltransferases are miR-203 
targets, both in mouse and human PSCs, responsible of at least part of the miR-203-
mediated effects. 
miR-203 expression results in global and reversible DNA hypomethylation 
in PSCs 
Given the critical role of Dnmt3a/b as de novo DNA methyltransferases we next 
analyzed the genome-wide methylation profile of control (un-induced) iPSCs and 
miiPSCs (after transient induction with Dox) as well as embryoid bodies derived from 
them (Fig. 5A). Wild-type and mutant iPSCs displayed similar levels of methylation 
before Dox and wild-type cells were not affected by this treatment. In contrast, transient 
induction of miR-203 for 5 days resulted in a genome-wide hypomethylation in 
miiPSCs, which was strikingly more prominent 20 days after withdrawal of Dox (t=25; 
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Fig. 5B-E and Datasets EV2, EV3), a time-point in which Dnmt3a/b transcript levels 
had already recovered after their repression in the presence of Dox (Fig. EV5A). 
Notably, the number of DNA methylation valleys (DMVs; (Xie, Schultz et al., 2013) 
and partially methylated domains (PMDs; (Lister, Pelizzola et al., 2009) were 
increasingly higher in miiPSCs with time (Fig. 5B and Dataset EV3); for instance, 131 
PMDs were found at t=0 while 548 and 6,555 PMD were found at t=10 and t=25, 
respectively. DNA methylation comparison between groups showed that 128 
differentially methylated regions (DMRs) out of 131 total DMRs (97.7%; t=10 versus 
t=0) and 12,542 out of 12,549 (99.9%; t=25 versus t=0) DMRs were hypomethylated in 
miiPSCs as a consequence of previous exposure to miR-203 (Fig. 5E). These gradual 
changes in methylation spread over a significant proportion of Transcription Start Sites 
(TSSs) in a genome-wide manner (Fig. 5F), and also affected genes of the 2C-signature 
(Fig. 5G and Dataset EV4), in line with the observed upregulation in the expression 
levels of these 2C markers. Further transcriptional analysis of these samples suggested 
that deregulated genes with affected DMRs were significantly enriched in chromatin 
regulators, or genes involved in DNA replication and cell division or embryonic 
morphogenesis among other pathways (Appendix Figure S9 and Appendix Table S5, 
S6). 
As validation of the genome-wide methylation analysis, bisulphite modification 
followed by clonal sequencing confirmed miR-203-dependent hypomethylation of the 
promoter region of the gene encoding the E74 Like ETS Transcription Factor 5 gene 
(Elf5), a protein involved in the differentiation of epithelial cells and trophoblast stem-
cell renewal and differentiation (Latos, Sienerth et al., 2015) (Fig. EV5B-E). 
Interestingly, the embryoid bodies derived from miiPSCs displayed higher global levels 
of DNA methylation and lower number of PMDs (Fig. 5B-E) in agreement with the 
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upregulation of Dnmt3a and Dnmt3b transcripts observed after induction of 
differentiation (Fig. EV5A). In line with the observations at a genome-wide scale, the 
Elf5 promoter was hypermethylated in embryoid bodies generated from miiPSCs during 
the differentiation process (Fig. EV5B, C). Previous data suggest that interfering with 
DNA methyltransferase expression or activity results in global hypomethylation in the 
genome (Blattler, Yao et al., 2014, Chen, Ueda et al., 2003, Jackson, Krassowska et al., 
2004, Liao, Karnik et al., 2015, Mikkelsen, Hanna et al., 2008). Expression of 
exogenous, miR-203-resistant forms of Dnmt3a/b rescued the hypomethylation 
observed after miR-203 induction both in the Elf5 DMRs (Fig. EV5D, E) as well as in a 
DMR located at the histone deacetylase Sirt6 gene (Fig. 5H), suggesting that these de 
novo DNA methyltransferases are critical targets of miR-203 in inducing genome-wide 
hypomethylation. 
Given the recent findings showing that a widespread loss of methylation in PSC 
cultures might be deleterious when accompanied by massive erasure of genomic 
imprints (Choi et al., 2017a, Yagi et al., 2017), we tested the methylation levels at 103 
different genes controlled by Imprinting Control Regions (ICR) in miiPSCs. Whereas 
miiPSCs displayed a progressive demethylation of genes (red signal at t=10 and t=25 in 
Fig. 5I; upper panel), demethylation of ICRs was very limited at t=10 and moderate at 
t=25 in the same samples (lower panel). Importantly, demethylation was in all cases 
fully recovered upon differentiation (miiPSC-derived EBs; Fig. 5I), suggesting that 
demethylation of miiPSCs, both in DMRs and ICRs, is manageable and reversible, and 
does not compromise neither the quality of miiPSCs nor their competence to 
differentiate.   
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Transient exposure to miR-203 improves differentiation and maturation 
into cardiomyocytes in a Dnmt3a/b-dependent manner  
Since transient expression of miR-203 improves the function of pluripotent cells in 
several assays, we next decided to directly testing the effect of expressing this miRNA 
during differentiation of PSCs into cardiomyocytes. The effect of miR-203 was first 
tested in primary cardiomyocytes isolated from neonatal (P1) rats that undergo further 
expansion and differentiation when cultured in vitro. miR-203 mimics triggered a 
transient burst of cell proliferation as measured by incorporation of the nucleotide 
analogue EdU (Fig. EV6A) and mitotic markers such as cyclin B1 (Fig. EV6B). 
Importantly, this increase in proliferation occurred in cardiac troponin T (cTnT)-
positive cells (Fig. EV6C) and resulted in cells with increased ratio of Myh6 versus 
Myh7 myosin heavy chain genes (Fig. EV6B), a developmentally regulated switch that 
correlates with cardiomyocyte maturation and cardiac performance(Miyata, Minobe et 
al., 2000).  
We also tested a cardiomyocyte differentiation protocol from wild-type iPSCs 
(Kattman, Witty et al., 2011). Mouse iPSCs were transiently transfected with miR-203 
or control mimics and 15 days later they were differentiated into cardiomyocytes using 
specific media and culture conditions (Fig. 6A). Transient exposure to miR-203 was 
accompanied by increased expression of cardiomyocyte differentiation transcripts such 
as myosin heavy chain (Myh), atrial natriuretic peptide (Nppa), cardiac troponin T 
(encoded by the Tnnt2 gene), markers for cardiac progenitors such as insulin gene 
enhancer transcription factor Isl1 and Tbx5 in iPSCs previously treated with miR-203 
mimics (Fig. 6B and EV6D). Importantly, transient exposure to miR-203 resulted in 
higher expression of not only differentiation but also maturation markers such as the 
potassium channel components encoded by the Kcnh2, Hcn1 and Kcna4 genes (Otsuji, 
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Minami et al., 2010), that were only minimally induced in cells treated with control 
mimic RNAs (Fig. EV6E). In line with these data, the beating frequency in 
cardiomyocytes derived from miR-203-treated iPSCs was significantly higher 
suggesting enhanced functionality (Fig. 6C and Movies EV1, EV2). Expression of miR-
203-resistant forms of Dnmt3a and Dnmt3b in parallel to miR-203 (Fig. 6A) prevented 
the upregulation of these differentiation and maturation markers (Fig. 6B, D) as well the 
increase in beating frequency (Fig. 6C), suggesting the relevance of the miR-203-




Multiple efforts in the last decade have focused on improving the developmental and 
differentiation potential of PSCs with the ultimate goal of using these cells in 
regenerative medicine. PSCs, and in particular iPSCs, are inefficient in the most 
stringent assays such as tetraploid complementation (Kang, Wang et al., 2009, Zhao, Li 
et al., 2009) and human-mouse interspecies assays (Mascetti & Pedersen, 2016, Wu, 
Greely et al., 2016). Improving culture conditions has been a major subject of research 
offering multiple options (Choi et al., 2017a, Yagi et al., 2017, Yang et al., 2017). The 
use of 2i/L clearly improves some properties of PSCs in vitro and has been widely used 
in the last years, although recent data indicates that prolonged use of these conditions 
results in reduced developmental potential in vivo (Choi et al., 2017a, Yagi et al., 2017). 
Recent alternatives include the use of Src inhibitors or the LCDM cocktail whose 
targets require further validation (Choi et al., 2017a, Yagi et al., 2017, Yang et al., 
2017). Despite these advances, the long-term effects of chemicals that perturb major 
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signaling pathways in the cell remain uncertain. In particular, it will be critical to study 
how these treatments affect the differentiation potential of PSCs towards specific cell 
lineages and the functional properties of the resulting cells. 
In this work, we report that transient expression of a single microRNA can 
expand functionality and differentiation plasticity of either mouse or human PSCs both 
in vitro and in vivo. Already-established PSCs display enhanced expression of a 
signature of the top ~280 transcripts characteristic of the 2-cell stage during embryonic 
development (Biase et al., 2014) after brief exposure to miR-203. Importantly, transient 
exposure to this microRNA results in i) enhanced differentiation into multiple tissues 
(e.g. including pancreas, bone marrow or trophoblast) in teratomas generated in vivo; ii) 
complex embryo-like structures observed after the injection of these cells into mice; iii) 
augmented efficiency in stringent tests for assessing developmental potency, such as 
tetraploid complementation assays and human-mouse interspecies chimeras. 
Remarkably, half of those all-iPSC mice produced with miiPSCs by tetraploid 
complementation reached the adulthood showing efficient germline transmission, which 
has been rarely found in previous reports (Choi et al., 2017a, Kang et al., 2009, Leitch, 
McEwen et al., 2013, Okita, Ichisaka et al., 2007, Stadtfeld, Apostolou et al., 2010, 
Yagi et al., 2017, Yang et al., 2017, Zhao et al., 2009). Similarly, human iPSCs cells 
transiently exposed to miR-203 contributed to interspecies human-mouse conceptuses 
with high efficiency (up to 100% contribution in vitro) compared to previous reports 
(Mascetti & Pedersen, 2016, Theunissen, Friedli et al., 2016, Wu et al., 2016). 
Importantly, miR-203 was able to improve the potential of Enhanced Pluripotent Stem 
(EPS) cells generated in special culture conditions (Yang et al., 2017), suggesting that 
exposure to this microRNA may be used in combination with other strategies aimed to 
optimize PSC culture conditions. 
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Endogenous miR-203 levels are transiently induced during early preimplantation 
development, suggesting that this microRNA may contribute to the specific expression 
profile of early blastomeres. The fact that brief exposure to miR-203 sequences 
improves the long-term developmental potential of miPSCs even many weeks and 
passages after its expression suggests an epigenetic mechanism. In fact, miPSCs display 
a hypomethylated state in chromatin that is self-sustained and accentuated several 
weeks after exposure to this microRNA implying a replication memory. Among the 
multiple miR-203 targets, de novo DNA methyltransferases Dnmt3a and Dnmt3b likely 
play an important role in this effect. In cancer cells, miR-203 expression has been 
previously shown to decrease DNMT3B protein levels leading to de novo methylation 
of cancer-related genes and decrease expression of their products including the 
xenobiotic transporter ABCG2 (Gasque Schoof et al., 2015, To et al., 2017). In ESCs, 
lack of these DNA methyltransferases is known to induce progressive hypomethylation 
of chromatin with passages (Chen et al., 2003, Liao et al., 2015) and knockdown of both 
Dnmt3a and Dnmt3b transcripts mimicked the effect of miR-203 in several assays. In 
addition, expression of miR-203-resistant-Dnmt3a and -Dnmt3b cDNAs significantly 
rescued the phenotypes induced by miR-203 including differentiation to mature 
cardiomyocytes. Of note, whereas the severe hypomethylation observed in Dnmt3a/b 
knockout cells blocks differentiation (Jackson et al., 2004, Okano, Bell et al., 1999), the 
hypomethylated state induced by miR-203 is reversible and differentiation is highly 
improved, when compared to untreated cells, and accompanied of potent de novo DNA 
methylation. Whereas the basis for these differences is unclear, given the promiscuity of 
microRNAs, miR-203 may have additional targets that could also cooperate with 
Dnmt3a/b repression in the effects of this microRNA in pluripotent cells.  
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Maintaining methylation of imprinted loci during preimplantation development 
is a process mediated by Dnmt1, rather than Dnmt3a or Dnmt3b (Branco, Oda et al., 
2008, Hirasawa, Chiba et al., 2008), in agreement with our data showing a limited effect 
in the demethylation of ICRs in miPSCs, in which Dnmt1 expression is not modified. 
Conditions in which ICRs are also demethylated are not appropriate for PSC function as 
ICR hypomethylation is frequently irreversible (Theunissen et al., 2016). In fact, the use 
of 2i/L conditions result in a widespread loss of DNA methylation including massive 
erasure of genomic imprints that do not recover methylation after differentiation 
protocols (Yagi et al., 2017)(Yagi et al., 2017), leading to defective developmental 
potential in chimerism studies or tetraploid complementation assays (Choi et al., 2017a, 
Yagi et al., 2017). On the contrary, transient exposure to miR-203 induces moderate and 
reversible ICR hypomethylation, that likely contributes to the differentiation and 
development potential of these PSCs when submitted to differentiation stimuli. 
Altogether, our data present miR-203 sequences as an easy-to-use and suitable 
tool to improve PSCs in vitro, by expanding their differentiation and developmental 
potential in vivo. In contrast to other protocols aimed to improve reprogramming into 
pluripotent cells (Bar-Nur, Brumbaugh et al., 2014, Chen, Guo et al., 2013, Li & Izpisua 
Belmonte, 2016, Mikkelsen et al., 2008, Takahashi & Yamanaka, 2016), the effects 
induced by miR-203 can be easily achieved through brief exposure to specific mimics in 
already-established pluripotent cultures. Together, we conclude that transiently 
modulating the DNA methylation landscape of miPSCs by short exposure to miR-203 
may enhance the performance of these cells in multiple functional assays, including the 
efficient differentiation and maturation to specific cellular lineages of interest in 





Animal models and procedures 
Animal experimentation was performed according to protocols approved by the CNIO-
ISCIII Ethics Committee for Research and Animal Welfare (CEIyBA). The miR-203 
inducible model was generated by cloning a 482-bp genomic mmu-mir203 sequence 
into the pBS31 vector for recombination into the ColA1 locus in ES cells following the 
strategy reported previously (Beard, Hochedlinger et al., 2006). The resulting knockin 
allele [ColA1(miR-203)] was combined with a Rosa26-M2rtTA allele [Rosa26(rtTA)] 
for doxycycline-dependent induction as described previously (Beard et al., 2006) (Fig. 
EV1A). These animals were maintained in a mixed C57BL6/J x 129 x CD1 genetic 
background. For subcutaneous teratomas, iPSCs were trypsinized and 2-3 million cells 
were suspended in 100 μl PBS supplemented with 0.1% glucose and were 
subcutaneously injected into both flanks of athymic nude mice (provided by Charles 
River). Teratomas were daily controlled and measured by a caliper and finally isolated 
when their diameters reached 1.5 cm. Animals were euthanized at that point and 
teratomas were weighted and processed for RNA extraction or histopathological 
analysis. For intraperitoneal injections, wild-type athymic mice were injected with 4-5 x 
105 iPSCs resuspended in 100 μl PBS supplemented with 0.1% glucose. Mice were 
supervised daily from the day of the injection. Usually, 30 or 40 days after injection 
mice were euthanized and the visceral teratomas and embryo-like structures were 
isolated and processed, either for RNA extraction or histopathological analysis.  
For chimera generation, iPSCs or ESCs (5–7 cells per embryo, 10 passages) 
were microinjected into C57BL/6J-Tyrc-2J/J blastocysts and transferred to Crl:CD1 
(ICR) pseudo-pregnant females. For tetraploid complementation studies, 2-cell stage 
Hsd:ICR(CD-1) embryos were harvested from pregnant females at E1.5 and 
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electrofused in 0.3 M mannitol using a BLS CF-150/B cell fusion instrument with a 250 
μm electrode chamber. The electric pulse conditions were 30 V amplitude, 31 μs width 
and 1.5 AC voltage. One to two hours later, 1-cell (tetraploid) embryos were selectively 
picked and cultured in KSOM overnight. Next day, 4-cell stage embryos were selected 
and aggregated with ESCs or iPSCs. Aggregated embryos were transferred to pseudo-
pregnant females 24 hours later. To study germline contribution, black ES-iPS-mice 
(from tetraploid complementation assays) were crossed with Albino C57BL/6J-Tyrc-
2J/J females and hair coat pigmentation was monitored in the progeny. 
Interspecies Chimeric Assays  
Human iPSCs were cultured in serum-free N2B27-LCDM medium under 20% O2 and 
5% CO2 at 37ºC (Yang et al., 2017). A total of 500 mL of N2B27 medium was prepared 
by including: 240 mL DMEM/F12 (Thermo Fisher Scientific, 11330-032), 240 mL 
Neurobasal (Thermo Fisher Scientific, 21103-049), 2.5 mL N2 supplement (Thermo 
Fisher Scientific, 17502-048), 5 mL B27 supplement (Thermo Fisher Scientific, 12587-
010), 1% GlutaMAX (Thermo Fisher Scientific, 35050-061), 1% nonessential amino 
acids (Thermo Fisher Scientific, 11140-050), 0.1 mM β-mercaptoethanol (Thermo 
Fisher Scientific, 21985-023), and penicillin-streptomycin (Thermo Fisher Scientific, 
15140-122). To prepare the N2B27-LCDM medium, small molecules and cytokines 
were added in the N2B27 medium as indicated at the following final concentrations: 10 
ng/ml recombinant human LIF (L, Peprotech, 300-05), 1 μM CHIR99021 (C, Tocris, 
4423), 2 μM (S)-(+)-Dimethindenemaleate (D, Tocris, 1425) and 2 μM Minocycline 
hydrochloride (M, Santa Cruz Biotechnology, sc-203339). Y-27632 (5 μM; Tocris, 
1254) was added 24 h before and after single cell passage. Human iPSCs were cultured 
on mitomycin C (Sigma-Aldrich, M4287)-inactivated mouse embryonic fibroblast 
(MEF) feeder cells (3*104 cells/cm2). The N2B27-LCDM medium was changed every 
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day with fresh LCDM medium. To maintain human iPSCs in an undifferentiated state, 
we used the following criteria: a) avoid plating human cells too sparsely; b) use the 
proper quantity of freshly prepared MEF feeder cells; and c) do not allow human cells 
to overgrow. iPSCs were passaged by Accumax (Innovative Cell Technologies) every 
3–5 days (normally at a split ratio ranging from 1:3 to 1:10), and the exact passage day 
and split ratio should be determined for each cell line specifically.  
For transient miR-203 expression, human iPSCs expressing the Tomato reporter 
were transfected with pMCSV-miR203-GFP. The cell pellet was resuspended with the 
Nucleofection/Plasmid mixture (P3 Primary Cell 4D-Nucleofector Kit, Lonza): 82 μL 
solution + 18 μL supplement1 + 2 μg plasmid. The cells were transferred into a cuvette 
for nucleofection using a 4D-Nucleofector (Program CB150, Lonza), and then seeded 
on DR4 MEFs. The next day, the cells were gently digested into single cells using 
Accumax. Suspensions were filtered through a cell strainer (40 μm). Then, the samples 
were loaded and sorted to harvest GFP+ and Tomato+ cells on a Becton-Dickinson 
Fusion sorter. After cell collection, they were plated on DR4 MEFs in N2B27-LCDM 
medium plus10 μM Y-27632. The medium was changed the next day without Y-27632. 
For interspecies chimeric experiments, human cells were used one day before 
passaging, which showed an optimal undifferentiated morphology and proliferated 
exponentially. At this time point, the colonies were at sub-confluent density 
(approximately 70% density of the day the cells should be passaged). 8-10-week ICR 
female mice were superovulated by the treatment of PMSG and 48 h later 
intraperitoneal administration of hCG. Female mice were then mated with a male for 
oocyte fertilization. Appearance of plugs were checked in female mice, and 2-cell stage 
embryos were harvested 1 day after that. 2-cell stage embryos were cultured in KSOM 
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for another 24h and named E2.5 embryos. At this time most of the embryos were 
around 8-cell stage and ready for human EPS cell injection. 
Human iPSCs were first rinsed with PBS, then treated with Accumax for 2 min 
and subsequently filtered through a cell strainer (40 μm). Cells were then centrifuged at 
1,200-1,500 rpm (250-300 g) at room temperature for 3 min. The supernatant was 
removed, and the cells were re-suspended in the culture medium at a proper density (2-
6*105 cells/ml). 10 μM Y-27632 was added into the suspension. The suspension was 
placed on ice before injection. One individual human cell (or 15 human cells, in 
Appendix Figures S6-7) was microinjected into each E2.5 ICR diploid mouse embryo. 
Injected embryos were cultured in N2B27-LCDM medium for the first 4 h (in the 
presence of 10 μM Y-27632), followed by culture for 44-60 h in mixed cell culture 
medium and KSOM medium at a 1:1 ratio. When the embryo reached the blastocyst 
stage, approximately 10 injected embryos were transferred to each uterine horn of a 2.5 
days post-coitum pseudo-pregnant ICR female, or fixed with 4% paraformaldehyde for 
immunostaining. Postimplantation embryos were collected at E9.5, rinsed in PBS, 
followed by embedding, freezing, slicing (10 μm thick) with a Cryostat. 
For immunofluorescence, embryos or slides were fixed in 4% paraformaldehyde 
(Sigma) at room temperature for 20 min and washed with PBST for 30 min. Samples 
were then permeabilized with 0.2% Triton X-100 in PBS. After 3 washings, samples 
were blocked with PBS (Corning, 21-040-CVR) that contained 1% BSA and 0.05% 
TWEEN-20 at room temperature for 45 min, and then incubated with primary 
antibodies at 4°C overnight. After 3 washings, secondary antibodies (Jackson 
ImmunoResearch) were incubated at room temperature for 1 hr. The nuclei were stained 
with DAPI (Southern Biotech). The following antibodies were used: anti-OCT4 
(C30A3) (1:200; Cell Signaling), Anti-HuNu (1:200; Novus, NBP2-34342), anti-CDX2 
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(1:200, CDX2-88; Biogenex), anti-Gata4 (1:200; Santa Cruz, C-20), anti-Sox2 (1:200; 
R&D, AF2108), anti-hSOX17 (1:200; R&D, AF1924) (Appendix Table S3). 
Immunofluorescence images were obtained using a confocal microscope and signals 
were then analyzed and quantified using ImageJ. 
All the chimeric experiments were reviewed and approved by the Salk 
Institutional Animal Care and Use Committee (IACUC) and followed the ethical 
guidelines of the Salk Institute. 
Cell culture and gene expression 
Primary mouse embryonic fibroblasts (MEFs) were obtained from embryos at E13.5 
and cultured in DMEM supplemented with 10% of FBS and Penicillin/Streptomycin. 
Cultures were routinely tested for mycoplasma. Regarding the miR-203 inducible 
model-derived MEFs, reprogramming was promoted on these MEF cultures by non-
inducible Oct4-Sox2-Klf4-cMyc (OSKM) lentiviral transduction. For lentiviral 
transduction, we transfected HEK293T cells with FUW-OSKM (Addgene #20328) and 
packaging vectors using Lipofectamine 2000 (Invitrogen). Viral supernatants were 
collected twice a day on two consecutive days starting 24 h after transfection and were 
used to infect MEFs, previously plated at a density of 250,000 cells per well in 6-well 
plates. Previous to infection, polybrene was added to the viral supernatants at a 
concentration of 2 μg/ml. For all those experiments in which miR-203 was expressed in 
WT iPSCs by mimics transfection or retrovirus transduction, WT MEFs reprogramming 
to obtain WT iPSCs was performed using inducible OSKM lentiviral transduction 
(TetO-FUW-OSKM; Addgene #20321). Infected MEFs were then cultured in iPSC 
medium, containing KO-DMEM (Gibco), 2-Mercaptoethanol 50 mM (Invitrogen), non-
essential aminoacids MEM NEAA (Invitrogen), Penicillin and Streptomycin (5000 
μg/ml, Invitrogen), Lif (Leukemia Inhibitor Factor, ESGRO, Millipore) and 20% 
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knock-out serum replacement (KSR, Invitrogen). In this case, doxycycline was also 
added to the iPSC medium to promote reprograming only for the generation of WT 
iPSCs to be treated with miR-203 mimics or retroviruses (but never in the case of iPSCs 
derived from the miR-203 inducible animal model, in which miR-203 expression 
depends on DOX addition). Medium was changed every 24 h and plates were stained 
for alkaline phosphatase activity to assure the efficiency of reprogramming (AP 
detection kit, Sigma-Aldrich). Once colonies were picked, iPSCs were cultured in iPSCs 
media over mitomycin C (Roche)-inactivated feeder cells. G4 ESCs were cultured over 
mitomycin C-inactivated feeders and in the presence of ESC medium containing KO-
DMEM, 2-Mercaptoethanol, non-essential amino acids, Glutamax, Penicillin and 
Streptomycin, Lif and 10% Fetal Calf Serum (Hyclone). When indicated, the culture 
media for pluripotent cells included 2i factors (MEK inhibitor PD0325901 1 μM, Gsk3 
inhibitor CHIR99021 3 μM) and mouse LIF (as above) in N2B27 medium, as described 
previously (Ying et al., 2008). For inducing transient miR-203 over-expression, 
ColA1(miR-203/miR-203); Rosa26(rtTA/rtTA) iPSC or ESC cultures were treated with 
Dox (1 μg/ml; Invitrogen) during 5 days. After that, Dox withdrawal was standardized 
for the cultures during following several passages (10-30 days) unless other time points 
are indicated in the text. In this inducible system, we always test that insert expression is 
uniquely dependent on Dox, and becomes absolutely undetectable after Dox 
withdrawal. As a control of the treatment itself, Dox was also added and tested in wild-
type iPSCs or ESCs. 
 For over-expression experiments, miR-203 and full-length cDNAs of Dnmt3a 
and Dnmt3b were subcloned into the retroviral vector pMCSV-PIG (Abad et al., 2013) 
by restriction-directed subcloning, using pCMV-Sport6-mDnmt3a (MGC clone:5662) 
and attB-mCh-mDnmt3b-Poly (A)-NeoR (Addgene plasmid 65553) as templates, 
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respectively. For retroviral transduction, we transfected HEK293T cells with the 
respective pMCSV-PIG vector expressing a GFP reporter (including either only GFP; 
miR-203-GFP; Dnmt3a-GFP or Dnmt3b-GFP) and the packaging vector pCL-ECO, 
using Lipofectamine 2000 (Invitrogen). Viral supernatants were collected twice a day 
on two consecutive days starting 24 h after transfection and were used to infect either 
ESCs or IPSCs, previously plated over feeders in 6-well plates. Preceding the infection, 
polybrene was added to the viral supernatants at a concentration of 2 μg/ml. When 
transduced with these retroviral vectors, both ESCs or iPSCs cells were sorted by FACS 
and GFP-positive cells were selected for subsequent cultures and analysis. For 
transfection with mimics, we used miRIDIAN microRNA human hsa-miR-203a-5p (C-
302893-00)/has-miR-203a-3p (C-300562-03) mimics or mimic transfection control 
(scramble sequences purchased from GE Dharmacon) with Dy547 (CP-004500-01), all 
of them from GE Dharmacon. Transfection was performed using either Dharmafect 
transfection reagent (Dharmacon) or Lipofectamine RNAiMAX (Invitrogen) following 
the manufacturer´s instructions. Transfection efficiency was evaluated 24 h post-
transfection by Dy547 fluorescence, and experiments were then performed as indicated 
in the figures.  
Regarding the use of the two mature forms of miR-203 mimics: as happens with 
many other microRNAs, two mature microRNAs can originate from opposite arms of 
the same pre-miRNA, has-miR-203a, which are denoted with a -3p or -5p suffix. 
However, the mature microRNA found from one arm of the hairpin is usually much 
more abundant than that found from the other arm, in which case, an asterisk following 
the name indicates the mature species found at low levels from the opposite arm of a 
hairpin. In the case of miR-203, the most abundant mature form is miR-203a-3p, while 
the low abundant form is called miR-203a-5p*.  
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Human miR-203 is expressed from chromosome 19. Its murine counterpart, 
mmu-miR-203 (Accession in miRbase MI0000246) is expressed from chromosome 14 
of Mus musculus. The main mature sequence of mmu-miR-203, mmu-miR-203-3p 
(Accession in miRbase MIMAT0000236) seems to be identical to that of hsa-miR203a-
3p. There are experimental evidences of a second mature sequence, mmu-miR-203-5p* 
(Accession in miRbase MIMAT0004547), which is shorter than hsa-miR-203a-5p (22 
nucleotides instead of 25) and differs slightly from its human counterpart in the rest of 
the sequence (in position 11, G is replaced by A in hsa-miR203a-5p*).  Both miR-203a-
3p/-5p were used in these assays, aiming to faithfully mimic the endogenous scenario in 
which both mature forms are expressed. However, the most abundant form (miR-203a-
3p) is responsible for the observed effects, as depicted for example in the Appendix 
Figure S10. 
For RNA interference assays, ON-TARGETplus SMARTpool for Non-targeting 
control siRNA (D-001810-01, 02, 03, 04), Dnmt3a siRNAs (J-065433-09, 10, 11, 12) 
and Dnmt3b siRNAs (J-044164-05, 06, 07, 08) from Dharmacon were used. 
Transfection was performed using Dharmafect transfection reagent (Dharmacon) 
following the manufacturer´s instructions. Transfection efficiency was evaluated 24 h 
post-transfection by qPCR, using the primers indicated in Appendix Table S4. A few 
weeks after transfection, the cells were assessed for differentiation to embryoid bodies. 
Luciferase reported assays were performed in HEK293T cells. Briefly, 200.000 
cells per well were seeded on 6-well plates and the day after, cells were transfected 
using Lipofectamine 2000 (Invitrogen), following the manufacturer´s instructions. The 
3´UTR regions from the murine genes Dnmt3a, Dnmt3b, Dnmt3l and Dnmt1 were 
amplified by PCR with specific primers (Dnmt3a_EcoRI-Fw: 5’-
GAATTCAGGGACATGGGGGCAAACTGAA-3’ (SEQ ID NO:55); Dnmt3a_NdeI-
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Rv: 5’-CATATGCTGAGGCAGTCATTTTAGATTCAT-3’ (SEQ ID NO:56); 
Dnmt3b_EcoRI-Fw: 5’-GAATTCTTTTAGCTCACCTGTGTGGGG-3’ (SEQ ID 
NO:57); Dnmt3b_NdeI-Rv: 5’-CATATGCCAGAAAGGTAAACTCTGGGCA-3’ 
(SEQ ID NO:58); Dnmt3l_EcoRI-Fw: 5’-
GAATTCGAAATGAATCACCATAAGATGAAAG-3’(SEQ ID NO:59); 
Dnmt3l_NdeI-Rv: 5’-CATATGAACAATCCTATGATATATTTGAAAAA-3’ (SEQ 
ID NO:60); Dnmt1_EcoRI-Fw: 5’-GAATTCGTGCTCTCACCCAGAGCCCCA-3’ 
(SEQ ID NO:61); Dnmt1_NdeI-Rv: 5’-
CATATGGCTTGACAGAAGCGCTTTATTTTG-3’) (SEQ ID NO:62) (Appendix 
Table S4), using cDNA clones (pCMV-Sport6-mDnmt3a, cDNA clone MGC:5662; 
pBluescript-mDnmt3l, RIKEN clone: 2410006021; pYX-Asc-mDnmt1, MGC 
clone:62302) or mouse cDNA (in the case of Dnmt3b). PCR products were verified by 
sequencing and ligated into the pGL3-Control vector (Promega), downstream of the 
luciferase reporter gene. Mutations in the miR-203 binding sites were generated by site-
directed mutagenesis and subsequently verified by sequencing. Transfections were 
performed with either pMCSV-GFP or pMCSV-miR-203-GFP vectors, in combination 
with the pGL3-derived vectors, and Renilla as a control. Luciferase measurement was 
achieved 48 h post-transfection using a luminescence microplate reader (Biotek).  
Murine ESCs expressing the 2C::tdTomato reporter to detect endogenous 
expression of the 2C-stage-retrotransposon MuERV-L were cultured in 2i media over 
feeders as reported previously (Macfarlan et al., 2012). Human iPSCs expressing the 
long terminal repeat (LTR7) of HERVH endogenous retroviruses fused with GFP 
reporter, (Wang et al., 2016) were cultured in mTeSRTM1 media (Stem Cell 
Technologies) over a Matrigel basement (Corning). Experimentation with human cells 
was performed according to protocols approved by the ISCIII Ethics Committee for 
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Research (CEI; number PI 61_2017) and the Salk Institute Ethics Committee for 
Research. 
Embryoid body generation 
Briefly, iPSCs or ESCs were trypsinized and resuspended to a concentration of 200,000 
cells/ml in the presence of complete growth medium lacking leukemia inhibitory factor 
(Lif). Small drops of this suspension (~35 μl) were collected and seeded on the lid of a 
10 mm plate, generating hanging drops of approximately 5,000 cells per drop. After 4 
days, the aggregates were already visible at the bottom of the drops and were picked and 
transferred to a non-adherent plate, containing DMEM and 10% Fetal Calf Serum. 
There they were maintained in suspension for the indicated times and beating, size and 
cavity formation were assessed every five days as described in the figures. Between 20 
and 30 EBs were analyzed per condition and the percentage of beating EBs or EBs with 
large cavities were calculated for every time point. EB size was measured using the 
Image J software. 
Immunofluorescence and immunohistochemistry 
Cells previously seeded in cover slips were fixed in 4% paraformaldehyde for 15 min, 
permeabilized using PBS 0.1% Triton X-100 for 15 min and blocked in BSA for 1 h at 
room temperature. Primary antibody incubation was performed overnight at 4ºC in all 
cases, followed by secondary antibody incubation for 1 hour at room temperature. 
Nuclear staining was included in the last PBS wash, using Hoechst or DAPI. Primary 
antibodies used in this study were against Cd34 (Abcam), Gata4 (Santa Cruz), Pax6 
(Abcam), Nestin (Millipore), cTnT (Abcam) and phospho-histone H3 (Millipore) 
(Appendix Table S3). Cells were examined under a Leica SP5 microscope equipped 
with white light laser and hybrid detection. 
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For immunohistochemistry, tissue samples were fixed in 10% neutral buffered 
formalin (4% formaldehyde in solution), paraffin-embedded and cut at 3 µm, mounted 
in superfrost®plus slides and dried overnight. Consecutive sections were stained with 
hematoxylin and eosin (H&E) or subjected to immunohistochemistry using automated 
immunostaining platforms (Ventana Discovery XT, Roche or Autostainer Plus Link 
48). Antigen retrieval was first performed with high or low pH buffer depending on the 
primary antibody (CC1m, Roche or low pH antigen retrieval buffer, Dako), endogenous 
peroxidase was blocked (peroxide hydrogen at 3%) and slides were incubated with 
primary antibodies against Nanog (Cell Signalling Biotechnology, 8822, )cytokeratin 8 
(CK8; CNIO Monoclonal Antibodies Core Unit, AM-TROMA I), GFP (Roche, 
11814460001), Sox2 (Cell Signaling Technology, 3728), alpha-fetoprotein (AFP; R&D 
Systems, AF5369), Oct4 (Santa Cruz Biotechnology, sc-9081), KI-67 (Master 
Diagnostica, 0003110QD), Nestin (Millipore, MAB353), Cd31 (Abcam), Cd34 
(ABCAM ab8158), Cd73 (Cell Signaling Technology), Collagenase Type I (Rockland), 
Gata4 (Santa Cruz Biotechnology, sc-1237),  Smooth muscle actin (Thermo Scientific, 
RB-9010-PO), skeletal actin (Dako, M0635) or Ter119 (LY-76; BD Bioscience, 
550565) (Appendix Table S3). Secondary antibodies were conjugated with horseradish 
peroxidase (OmniRabbit, Ventana, Roche) and the immunohistochemical reaction was 
developed using 3,30-diaminobenzidine tetrahydrochloride (DAB) as a chromogen 
(Chromomap DAB, Ventana, Roche or DAB solution, Dako) and nuclei were 
counterstained with Carazzi’s hematoxylin. Finally, the slides were dehydrated, cleared 
and mounted with a permanent mounting medium for microscopic evaluation. The 
images were acquired with a slide scanner (AxioScan Z1, Zeiss). Images were captured 




For western blotting, cells were lysed in RIPA or a buffer containing 50mM Tris HCl, 
pH 7.5, 1mM phenylmethylsulphonyl fluoride, 50mM NaF, 5mM sodium 
pyrophosphate, 1mM sodium orthovanadate, 0.1% Triton X-100, 1 μg/ml leupeptin, 
1mM EDTA, 1mM EGTA and 10mM sodium glycerophosphate. Thirty micrograms of 
total protein were separated by SDS-PAGE and probed with primary antibodies against 
Dnmt3a (Novus Biological, 64B1446), Dnmt3b (Novus Biological, 52A1018) or 
Vinculin (Sigma, V9131). 
Analysis of mRNA and microRNA levels 
RNA was extracted from cell or tissue samples with Trizol (Invitrogen) or by using the 
miRVana miRNA isolation kit (Thermo Fisher), following the manufacturer´s 
recommendations. Retrotranscription into cDNA was performed using M-MLV Reverse 
Transcriptase (Promega) following the manufacturer’s protocol. Quantitative real time 
PCR was performed using Syber Green Power PCR Master Mix (Applied Biosystems) 
in an ABI PRISM 7700 Thermocycler (Applied Biosystems). The housekeeping gene 
Gapdh was used for normalization. The oligonucleotide primers used in this manuscript 
are listed in the Appendix Table S4. For reverse transcription of microRNAs, we used 
the Taqman small RNA assay (4366596), including the specific oligonucleotides for 
mmu-miR-203-5p and 3p (002580 and 000507), miR-16 and the housekeeping RNAs 
sno-202 or sno-142. Conditions for miRNA amplification were as follows: 30 minutes 
at 16ºC; 30 minutes at 42ºC and a final step of 5 minutes at 85ºC. Quantitative real time 
PCR was then performed using the Taqman Universal PCR Master Mix (434437) 
following the manufacturer´s instructions in an ABI PRISM 7700 Thermocycler 
(Applied Biosystems).  
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 For RNAseq, total RNA was extracted using the miRVana miRNA isolation kit 
(ThermoFisher), following the manufacturer´s recommendations. Between 0.8 and 1 µg 
of total RNA was extracted from iPSCs, ESCs or teratomas, with RIN (RNA integrity 
number) numbers in the range of 9 to 10 (Agilent 2100 Bioanalyzer). Poly A+ fractions 
were purified and randomly fragmented, converted to double stranded cDNA and 
processed using the Illumina's "TruSeq Stranded mRNA Sample Preparation Part # 
15031047 Rev. D" kit. The adapter-ligated library was completed by PCR with Illumina 
PE primers (8-11 cycles) and the resulting directional cDNA libraries were sequenced 
for 50 bases in a single-read format (Illumina HiSeq2000) and analyzed with nextpresso 
(Graña, Rubio-Camarillo et al., 2017). Reads were quality-checked with FastQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc) and aligned to the mouse 
genome (GRCm38/mm10) with TopHat-2.0.10 (Trapnell, Roberts et al., 2012), using 
Bowtie 1.0.0 (Langmead, Trapnell et al., 2009) and Samtools 0.1.19 (Li & Durbin, 
2009), allowing two mismatches and five multihits. Transcripts assembly, estimation of 
their abundances and differential expression were calculated with Cufflinks 2.2.1 
(Trapnell et al., 2012), using the mouse genome annotation data set GRCm38/mm10 
from the UCSC Genome Browser (Rosenbloom, Armstrong et al., 2015). A false 
discovery rate (FDR) of 0.05 is used as threshold for significance in differential 
expression. Heatmaps were later built using GENE-E 
(http://www.broadinstitute.org/cancer/software/GENE-E/index.html). Published 
datasets (MacFarlan et al. (GSE 33923); Najm et al. (GSE 26814), (Yang et al., 2017) 
were compared using the ‘Feature Specific Quantile Normalization’ method, that allows 




Bisulphite conversion, genome-wide DNA methylation and validation of DMRs 
DNA samples were prepared for whole genome bisulphite sequencing using the 
TrueMethyl® Whole Genome Kit (CEGX®) according to the manufacturer’s 
instructions. Briefly, 200 ng of genomic DNA was sheared to 800 bp using M220 
Focused-ultrasonicator™(Covaris®). Then the fragmented DNA was denatured and 
oxidised by a chemical oxidant to convert 5-hydroxymethyl cytosine to 5-
formylcytosine (5fC). The purpose of the oxidation was to ensure that we purely 
captured the information for 5’ methyl cytosine methylation and not an 
indistinguishable pattern combination of 5’methyl cytosine and 5’hydroxymethyl 
cytosine. Following oxidation, the DNA was subjected to bisulphite conversion for the 
deamination of cytosines and 5fC to uracils. Bisulphite converted DNA was 
desulfonated and purified to then proceed to library preparation. In this “post- bisulphite 
conversion” library preparation method, the fragmented single stranded bisulphite 
converted DNA was adapted with sequencing adaptors at the 3’end followed by an 
extension step and finally ligation of adaptors at the 5’ end of the molecules. Finally, the 
libraries were indexed and amplified. The PCR was performed for 10 cycles followed 
by bead-based purification. An additional purification and size selection step using 
Agencourt AMPure XP beads (Beckman Coulter, Cat: A63881) was performed to 
remove adaptor dimers. The purified library was eluted in a final volume of 14 μl pure 
water. Quality of the library obtained was checked using the DNA High sensitivity chip 
on the Agilent Bioanalyzer. The library was quantified using Qubit and KAPA 
Biosystems Library quantification kit (#KK4824) according to manufacturer’s 
instructions. A total of 1-2pMol of multiplexed libraries were sequenced on a 125 bp 
paired-end format (Illumina HiSeq2500). Adapter sequences were removed using 
cutadapt version 1.9.1 (Martin, 2011) in paired-end mode with parameters “-m 15 -u 6 -
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U 6”. Bwa-meth (Pedersen, Eyring et al., 2014) was then used to align reads to mm10 
using default parameters. PCR duplicates were removed using Picard v1.91 
(http://broadinstitute.github.io/picard). Count tables of the number of methylated and 
unmethylated bases sequenced at each CpG site in the genome were constructed using 
the "tabulate" module of bwa-meth and BisSNP-0.82.2 (Liu, Siegmund et al., 2012) 
with default parameters. All libraries passed basic quality control checks with a 
minimum of 82.7% of read pairs aligning uniquely. DMRs were called using the WGBS 
module of DMRcate (Peters, Buckley et al., 2015) with parameters lambda=1000 and 
C=50, DMPs were called using DSS (Feng, Conneely et al., 2014), PMDs, LMRs and 
UMRs were called using MethylSeekR (Burger, Gaidatzis et al., 2013) and PMDs were 
called using the R package 'aaRon' (https://github.com/astatham/aaRon). 
For the validation of DMRs, clonal bisulphite sequencing was performed at two 
particular loci:  Elf5 (chr2: 103, 423, 778-103, 424, 180) and Sirt6 (chr10: 81, 624, 595-
81, 625, 547) promoter regions. 100 ng of DNA was bisulphite treated using EZ DNA-
Methylation-LightingTM kit (Zymo Research) following manufacturer’s instructions. 
Triplicate PCR amplifications were then performed using semi-nested bisulphite 
conversion specific primers listed in Appendix Table S4, following the PCR conditions 
previously described for Elf5 (Lee, Hinshelwood et al., 2011) or using the following 
protocol: 95ºC 4 min; 5 cycles (95ºC 45 sec, 54ºC 1.5 min, 72ºC 2 min); 25 cycles 
(95ºC 45 sec, 54ºC 1.5 min; 72ºC 1.5 min) and final extension at 72ºC 4 min, for Sirt6. 
The methylation status of the PCR amplicons was determined by Sanger clonal 
sequencing of the pooled PCR products to ensure representative clonal analysis using 
between 8-10 clones per sample. The analysis of the methylation status of the clones 
was performed using BiQ Analyzer (Bock, Reither et al., 2005). 
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Neonatal cardiomyocyte isolation and differentiation studies 
Neonatal mouse and rat cardiomyocytes were prepared as described previously (Huang, 
Kataoka et al., 2015). Briefly, neonatal cardiomyocytes were isolated by enzymatic 
disassociation of 1-day-old neonatal mouse or rat hearts with the Neonatal 
Cardiomyocyte Isolation System (Cellutron Life Technology). Cardiomyocytes were 
pre-plated for 2 hours to remove fibroblasts. Cells were then plated on 1% gelatin-
coated plates in medium containing 10% horse serum and 5% fetal calf serum. Eighteen 
hours after plating, cells were changed into serum-free medium and then transfected 
with 50 nM miR-203a-3p & 5p mimics or control mimics (from Dharmacon) by using 
Lipofectamine RNAiMAX transfection reagent, following the manufacturer´s 
instructions. Six hours later, media with transfection reagent were removed and 
substituted by media containing 1% serum. Different time points (as indicated) were 
collected for subsequent RNA extraction and EdU staining/immunofluorescence. For 
EdU staining, we used the Click-iT EdU staining Kit (Invitrogen) following the 
manufacturer´s recommendations. After that, immunofluorescence of cardiomyocytes 
markers (Troponin T) was performed and Hoechst was finally used for nuclei staining.  
For in vitro differentiation from mouse iPSCs to cardiomyocytes, wild-type 
mouse iPSCs were transfected with either control or miR-203 mimics prior to 
differentiation. In some experiments, additionally pMCSV-Dnmt3a and 3b or empty 
pMCSV vector were transiently transduced, 24 hours after mimics transfection. iPSCs 
were then maintained in culture under 2i/Lif media for 15 days, before differentiation 
started. Then, cells were plated in Matrigel pre-coated 6-well plates. Once they become 
confluent, the media was changed to RPMI 1640/B27 medium (Thermo Fisher 
Scientific, 61870127 for the RPMI 1640 media and A1895601 for B27) with 
CHIR99021 5 μM (Stem Cell Technologies, 72054). After two days, cells were washed 
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and media without CHIR99021 was added. At day 3 of differentiation, media was 
supplemented with IWR1 5 μM (Stem Cell Technologies, 72564) and maintained in 
these conditions for 2 more days. At day 7 of differentiation, the media was changed to 
RPMI 1640/B27 plus insulin. Then, from day 9 to day 15, cells were cultured in RPMI 
1640/B27 and the media was changed every 2 days. From day 16 to day 18 of 
differentiation, cells were cultured in DMEM without glucose and with lactate 4mM. 
From day 18 to day 21, the media was changed to RPMI 1640/B27 and changed every 
day. Finally, from day 22 to day 28, monolayer cells can be isolated into cell clusters 
and kept in low attachment for another week.  
Statistics 
Normal distribution and equal variance was confirmed before using the Student’s t-test 
(two-tailed, unpaired) to estimate statistical significance. For contingency tables, we 
used the Fisher’s exact test. Statistical analysis was performed using Prism (GraphPad 
Software, La Jolla, CA). 
Data availability 
RNAseq and methylation data has been deposited in the GEO repository under 
accession numbers GEO SuperSeries GSE81571 and GSE86653. 
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Figure 1. Effects of transient induction of miR-203 in iPSC and ESC pluripotency 
and differentiation potential.  
A, miR-203 expression, as determined by qPCR, in five temporal different stages of 
normal early development: oocyte, 2-cell embryo, morula, compacted morula and 
blastocyst. RNA was extracted from 30 different embryos and pooled in two 
independent groups for analysis by qPCR. RNA expression is normalized by a 
housekeeping miRNA (miR-16) that maintained invariable during early embryogenesis.  
Data represent the mean of 6 different qPCR measures (red bars). P=0.05 (Student’s t-
test) comparing 2C/morula versus compacted morula/blastocyst.  
B, Protocol for reprogramming of miR-203 mutant MEFs into pluripotent iPSCs and 
subsequent differentiation into embryoid bodies. MEFs were transduced with 
lentiviruses expressing Oct4, Sox2, Klf4, and cMyc (OSKM) in a constitutive manner. 
The resulting iPSCs were then treated with doxycycline (Dox) 1 μg/ml during 5 days to 
induce miR-203 expression. “miiPSCs” refers to iPSCs in which miR-203 was 
transiently expressed during the indicated 5 days. Dox was removed for 15-30 days 
before starting the embryoid body generation protocol. Samples for RNA sequencing 
were taken 30 days after Dox withdrawal.   
C, Principal Component Analysis of RNAseq data from wild-type iPSCs (n=3 clones), 
miiPSCs (n=4) and wild-type ESCs (n=3).  
D, Enrichment plots of the 282-gene 2-cell signature (Biase et al., 2014) in miiPSCs 10 
and 25 days after Dox withdrawal.  
E, PCA analysis of RNA-seq and microarray data from miiPSCs and known already-
published PSC types. Log2 expression values were normalized to mESCs in each study. 
Data from miiPSCs (this study), mES cells (each study), 2C-like cells (MacFarlan et al, 
2012) and epiblast stem cells (Najm et al, 2011) were analyzed and a total of 17,243 
genes were selected. For miiPSCs, clones 1 and 2 were analyzed 10 days after miR-203 
exposure, while clones 3 and 4 were analyzed 25 days after miR-203 exposure (see 
schematic shown in Figure 1B). For Tomato PSCs, Tomato fluorescence is associated to 
2C-like retrotransposon expression, thus Tomato-positive cells are identified as 2C-like 
cells (MacFarlan et al, 2012).  
F, Representative images of embryoid bodies (EBs) derived from wild-type iPSCs or 
ESCs, or from miiPSC and miESCs at day 30 of differentiation. Scale bars, 500 μm.  
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G, Quantification of the percentage of EBs from panel (F) presenting internal large 
cavities and EBs beating during the indicated time course. Data are represented as mean 
± s.e.m. (n=3 independent experiments). *P<0.05; ***P<0.001 (Student´s t-test).  
H, Representative images of EBs derived from human iPSCs transiently transfected 
with either control (left) or miR-203 mimics (right), at different time points during the 
differentiation process. Scale bars, 500 μm.  
I, Left panel shows the quantification of EBs size derived from human iPSCs transiently 
transfected with either control or miR-203 mimics as in panel (H) at different time 
points during the differentiation process. The percentage of EBs presenting internal 
large cavities during the indicated time course of differentiation is shown in the right 
panel. Data are mean ± s.e.m. (n=3 independent experiments). ***P<0.001 (Student´s t-
test). 
 
Figure 2. Transient exposure to miR-203 in vitro improves the in vivo 
developmental potential of iPSCs and ESCs.  
A, Teratoma volume (mm3) 20-25 days after subcutaneous injection of wild-type iPSCs 
or miiPSCs expressing GFP. Data are represented as mean ± s.e.m. (n=8 tumors per 
genotype; 292,8 ± 66,67 versus 1216 ±140,1; difference between means: 923,5 ± 155,2; 
95% confidence interval: 1256 to -590,7); ***P<0.001 (Student´s t-test). Representative 
images are shown in Fig. EV2.  
B, Incidence and representative images of specific highly differentiated tissues in 
teratomas. The number of tumors included in the analysis is indicated in the panel. 
***P<0.001 (Student´s t-test). Scale bars, 50 μm.  
C, Table showing the frequency of nude mice with embryo-like structures (E-Ls) in 
their abdominal cavity 20-30 days after intraperitoneal (i.p.) injection of 400.000-
500.000 in vivo (iv)-generated wild-type iPSCs, un-induced iPSCs, or miiPSCs. The 
number of independent clones tested per condition is indicated in the panel (each animal 
was inoculated with a different clone).  
D, Representative example of E-Ls generated after i.p. injection of GFP-expressing 
miiPSCs. H/E, hematoxylin and eosin. The following antigens were detected by 
immunohistochemistry: Sox2 (ectoderm), Cd34 (mesoderm), Gata4 (endoderm), AFP 
and CK8 (visceral endoderm of the yolk sac) and Ter119 (nucleated erythroid cells). 
Scale bars, 500 μm and 100 μm for higher magnifications.  
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E, Embryo tetraploid complementation assays with un-induced iPSCs, miiPSCs or wild-
type ESCs (n=3 clones per condition). Pictures on the right show a representative 
example of a viable “all-miiPSC” mouse (black) generated from miiPSCs and litters 
obtained from “all-miiPSC” adult mice, which efficiently contributed to germline 
transmission. 
 
Figure 3. miR-203-exposed human iPSCs efficiently contribute to human-mouse 
interspecies chimeras.  
A, Summary of chimera assays in which one single Td-Tomato fluorescent-labeled 
human iPSC, either control or transiently transfected with miR-203-expressing vectors 
(miiPSCs) was injected into 8C-stage mouse embryos and their contribution analyzed 
48-60 h later. P values are indicated in the Figure (Student´s t-test). 
B, Representative images showing the contribution of human control iPSCs or miiPSCs 
cells to mouse blastocysts. These structures were co-immunostained with (human) anti-
OCT4 and anti-HuNu antibodies. Td-Tomato, red; Scale bars, 50 μm.  
C, Interspecies chimera assays in which the 8C-stage mouse embryos indicated in (A, 
B), injected with one single human iPSCs and cultured in vitro for 48 h to reach the 
blastocyst stage, were then transfected to 2.5 days post coitum pseudo-pregnant females. 
The post-implantation mouse conceptuses were dissected at the E9.5 developmental 
stage and analyzed by immunofluorescence. Representative images showing the 
integration of control human iPSCs (top) or miiPSCs (bottom) into mouse E9.5 
embryos. Anti-human HuNu antibody was co-stained with Td-Tomato direct 
fluorescence to detect human cells in E9.5 mouse embryos. Scale bars, 20 μm.  
D, E, Quantification of the Td-Tomato-(D) or HuNu-(E) positive area in 40-50 different 
cryosections of these embryos randomly and blindly selected for IF analysis. Data are 
mean ± s.e.m.  **P<0.01; ***P< 0.001 (Student´s t-test). 
 
Figure 4. DNA methyltransferases 3a and 3b are miR-203 targets involved in the 
regulation of PSCs potential.  
A, Venn Diagrams representing common genes down-regulated in miiPSCs, predicted 
as miR-203 targets and also involved in the epigenetic regulation of gene transcription 
(GO:0040029). The list of the common 18 transcripts (including Dnmt3a and Dnmt3b) 
is presented as Appendix Table S2.  
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B, C, Relative Luciferase Units (RLU; normalized to Renilla luciferase and relative to 
DNA amount) in 293T cells transfected with DNA constructs carrying the wild-type 
3´UTRs from the indicated transcripts (B) or the mutated versions of Dnmt3a and 
Dnmt3b 3´UTRs, downstream of the luciferase reporter (C). Cells were co-transfected 
with Renilla luciferase as a control of transfection, and a plasmid expressing GFP or 
miR-203-GFP. Data are represented as mean ± s.d. (n=3 independent experiments).  
D, Principal Component Analysis from RNAseq data including profiles from wild-type 
iPSCs, miiPSCs, and wild-type iPSCs transfected with either control siRNAs (siC), or 
siRNAs specific against Dnmt3a (siDnmt3a), Dnmt3b (siDnmt3b) or both (siDnmt3a/b).  
E, Representative images of embryoid bodies (EBs) derived from wild-type iPSCs in 
which the expression of Dnmt3a and Dnmt3b was transiently repressed by siRNAs. 
Scale bars, 500 μm. Plots show the quantification of the size of EBs and the percentage 
of EBs with large cavities or beating at different time points during the differentiation 
process. Data are represented as mean ± s.e.m. (n=3 independent experiments).  
F, Expression levels of Dnmt3a or Dnmt3b transcripts after transfection of wild-type 
iPSCs with specific siRNAs either against Dnmt3a, Dnmt3b or a combination of both 
(Dnmt3a/b) (as indicated in E). RNA expression was measured 24 hours after the 
transfection protocols and was normalized by GAPDH mRNA levels. Data are 
represented as mean ± s.e.m. (n=3 independent experiments).  
G, Representative images of EBs derived from miiPSCs that were transiently and 
simultaneously transduced with Dnmt3a and Dnmt3b cDNAs or empty vectors, and 
simultaneously treated with Dox to induce miR-203 expression. Scale bars, 500 μm. 
Plots show the quantification of EB size, percentage of EBs with large cavities, and 
beating EBs at different time points during differentiation. Data are represented as mean 
± s.e.m. (n=3 independent experiments). 
H, Expression levels of miR-203, Dnmt3a or Dnmt3b transcripts in iPSCs after 
induction of miR-203 (miiPSCs) and transduced with Dnmt3a and Dnmt3b cDNAs or 
empty vectors (as indicated in G). RNA expression was measured 24 hours after the 
transfection protocols and was normalized by a control miRNA (miR-142) or GAPDH 
mRNA, respectively. Data are represented as mean ± s.e.m. (n=3 independent 
experiments).  




Figure 5. Transient expression of miR-203 induces genome-wide hypomethylation 
in iPSCs.  
A, Experimental design for the genome-wide DNA methylation analysis of wild-type 
and miiPSC as well as embryoid bodies (EBs) derived from them. Cells (two 
independent miiPSC clones and two iPSC technical replicates) were transiently treated 
with Dox for 5 days and then subjected to Dox withdrawal for 20 additional days before 
starting the EB formation protocol. Samples for DNA and RNA analysis were collected 
at the indicated time points before Dox (t=0), 5 days after Dox withdrawal (t=10), 20 
days after Dox withdrawal (t=25) or 7 days after starting the EB generation protocol 
(t=32 days).  
B, Genome-wide DNA methylation data showing the number and total size of DNA 
methylation valleys (DMVs) and partially methylated domains (PMDs).  
C, DNA methylation distribution of the indicated samples, smoothed over 100 kb-
blocks.  
D, Principal Component Analysis showing the distribution of methylation profiles in the 
indicated samples (color code as in panel B).  
E, Number of differentially methylated single CpG sites (DMPs) and differentially 
methylated regions (DMRs) in the indicated comparisons (color code as in panel B).  
F, Heat-scatterplots representing the mean methylation over all transcripts (transcription 
start sites, TSSs) in mm10, pairwise for “t=10 vs. t=0” (left panel) and “t=25 vs. t=0” 
(right panel). Note that especially for “t=25 vs. t=0” most of the points are below the 
diagonal, indicating broad hypomethylation across most of the genome.  
G, Heat-scatterplots representing the mean methylation over the TSS of the 282 genes 
included in the 2-cell signature (as in Fig. 1D). Analysis as in (F).  
H, The specific differentially methylated regions (DMR) at the Sirt6 locus were 
analyzed by PCR amplification and sequencing of bisulphite-modified DNA. Ten 
independent clones were sequenced per condition. The quantification of methylated 
(filled circles) vs. unmethylated (empty circles) CpGs is shown in the histogram in the 
indicated conditions.  
I, Heatmaps representing the methylation levels at the top Differentially Methylated 
Regions (DMRs; n=100; upper panel) or the Imprinting Control Regions (ICRs; n=103 
different imprinting loci; lower panel) in the indicated samples (referred to panels A,B). 





Figure 6. Transient exposure to miR-203 enhances differentiation into mature 
cardiomyocytes and improves cardiac regeneration.  
A, Experimental protocol followed for the differentiation of cardiomyocytes from iPSCs 
in the absence or presence of miR-203 mimics and Dnmt3a/b cDNAs.  
B, Representative immunofluorescences showing cardiac Troponin T (cTnT, green) and 
nuclei (Hoechst, blue) staining of in vitro-generated cardiomyocytes derived from wild-
type iPSCs transiently transfected with either control mimics, miR-203 mimics or miR-
203 mimics + Dnmt3a/b cDNAs. Pictures were taken at day 15 of differentiation. Scale 
bars, 68 μm. The cTnT-positive area in these cardiomyocytes is shown in the right 
histogram. Data are represented as mean ± s.d. (n=2 independent experiments with 6 
replicates each).  
C, Beating frequency (measured as number of beats per 5 seconds) of these 
cardiomyocytes at day 15 of differentiation.  Data are represented as mean ± s.d. (n=8 
independent replicates). 
D, miRNA or mRNA levels as determined by quantitative PCR of the indicated 
transcripts at different time points during cardiomyocyte differentiation in the indicated 
samples. Data are represented as mean ± s.d. (n=2 independent experiments with 6 
replicates each).  
Data information: In (B, C, D), *P<0.05; **P<0.01; ***P<0.001 (Student´s t-test). 
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Figure EV1. Mouse alleles generated and used in this work, transcriptomic 
analysis of miiPSCs and validation of miR-203 mimics and vectors on EBs 
differentiation.  
A, Schematic representation of the miR-203 inducible knockin model generated in this 
work. In the ColA1(miR-203/miR-203); Rosa26(rtTA/rtTA) model, the reverse 
tetracycline transactivator is expressed from the Rosa26 locus, whereas miR-203 is 
driven by the tetracycline operator downstream of the ColA1 locus.  
B, miR-203 expression, as determined by quantitative PCR, in ColA1(miR-203/miR-
203); Rosa26(rtTA/rtTA) MEFs, iPSCs and ESCs treated or not with doxycycline 
(Dox). miR-203 expression is normalized by a control miRNA (miR-142). Data are 
mean ± s.d. (n=3 independent experiments). ***P<0.001 (Student´s t-test).  
C, Time course of miR-203 expression, as determined by qPCR. RNA expression is 
normalized by a housekeeping miRNA (miR-16) that maintained invariable.  Data are 
mean ± s.d. (n=4 independent replicates).  P<0.001 (Student´s t-test) comparing Dox 
treatment (green box) versus Dox withdrawal.  
D, Unbiased clustering of genome-wide RNAseq data (left) and heatmap plot showing 
the comparative expression of 450 genes associated with pluripotency (Chung, Lin et 
al., 2012); 2 clones per sample.  
E, Early expression (RPKM) of the indicated transcripts included in the 2C-signature. 
Data are mean ± s.e.m (n=3 independent experiments). *P<0.05; **P<0.01 (Student´s t-
test).  
F, Top categories in the Gene Ontology Analysis of the genes significantly upregulated 
in miiPSCs versus un-induced iPSCs (4 independent clones were analyzed; see also 
Dataset EV1). P-values were calculated by Fisher´s exact test. 
G, (Upper panels), Representative images of EBs derived from either wild-type iPSCs 
(left) or ESCs (right) transduced with empty pMCSV vector, pMCSV-miR-203 or 
transfected with control mimics or miR-203 mimics, at day 30 of the differentiation 
process. Scale bars, 500 μm. (Lower panels), Quantification of EBs with large cavities 
and beating EBs during the differentiation process. Data are mean ± s.e.m (n=3 
independent experiments). **P<0.01 (both in iPS and ES cells; Student´s t-test). 
  
Figure EV2. Histopahological analysis of teratomas generated from miiPSCs.  
A, Representative images of teratomas 20-25 days after subcutaneous injection of wild-
type iPSCs or miiPSCs expressing GFP, as indicated in Fig 2A. Images on the right 
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show an example of a miiPSC-derived embryo-like structure, analyzed 20 days after 
intraperitoneal (i.p.) injection of miiPSCs expressing GFP. Scale bar, 5 mm (two left 
panels), 1 mm (two right panels).  
B, Representative example of a highly differentiated teratoma generated from miiPSCs 
after i.p. injection in nude mice. Most of these complex teratomas were detected in the 
proximity of the uterus or as ovarian cysts in the host mice. The panel shows higher 
magnifications (H&E staining) of several differentiated tissues and cells observed in the 
teratoma. Scale bars, 1 mm (central image) or 50 μm (insets).  
C, Histopathological examples (H&E staining) of specific tissues found in miiPSCs-
derived teratomas. Scale bars, 100 μm. A magnification of a trophoblast giant cell 
stained against Placental Lactogen-1 (PL-1) is also shown (scale bar, 50 μm). 
 
Figure EV3. miR-203-exposed human iPSCs efficiently contribute to human-
mouse interspecies chimeras.  
A, Summary of interspecies chimera assays in which one single Td-Tomato fluorescent-
labeled human iPSC, either control or transiently transfected with miR-203-expressing 
vectors (miiPSCs), was injected into 8C-stage mouse embryos. These embryos were 
cultured in vitro for 48 h to reach the blastocyst stage and then transfected to 2,5 days 
post coitum pseudo-pregnant females. The post-implantation mouse conceptuses were 
dissected at the E9.5 developmental stage and analyzed by immunofluorescence.  
B, Representative immunofluorescence images from these E9.5 embryos summarized in 
panel A. Anti-human HuNu antibody was co-stained with Td-Tomato direct 
fluorescence to detect human cells in E9.5 mouse embryos. Scale bars, 20 μm.  
C, Representative immunofluorescence images from these E9.5 embryos summarized in 
panel A, co-stained with human HuNu antibody and Gata4, Sox2 or hSOX17 antibodies 
showing differentiation and proper integration of human cells into the mouse embryo. 
Scale bars, 20 μm.  
 
Figure EV4. miR-203 targets Dnmt3a/b 3’-UTR sequences.  
A, Dnmt3a and Dnmt3b 3´UTR alignment in several representative species. The seed 
region of the miR-203 target site contained in these 3´-UTRs is highlighted in blue and 
aligned with the corresponding miR-203 seed sequence.  
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B, Schematic representation of the luciferase reporter, carrying the wild-type Dnmt3a 
(left) or Dnmt3b (right) complete 3´-UTRs or the corresponding mutated versions, 
downstream of the luciferase gene. The seed region of the miR-203-target site contained 
in these 3´-UTRs is written in blue and aligned with the corresponding miR-203 seed 
sequence.  The mutated residues are indicated in red.  
C, Major pathways from the Gene Ontology database upregulated in wild-type iPSCs 
treated with specific siRNAs against Dnmt3a and Dnmt3b versus scrambled sequences 
(siC). P-values were calculated by Fisher´s exact test. 
D, Representative images of embryoid bodies (EBs) generated from wild-type iPSCs 
treated with specific siRNAs either against Dnmt3a or Dnmt3b (left panel) or 
transfected with a combination of miR-203-resistant Dnmt3a/b cDNAs (right panel) at 
the indicated time points during the differentiation process. Scale bars, 500 μm. 
E, Detection of Dnmt3a (117 KDa) and Dnmt3b (96 KDa) protein levels by western 
blot, in 5 independent clones of mouse un-induced iPSCs or miiPSCs and one human 
cell line, transfected with mimics control (hiPSCs) or miR-203 mimics (hmiiPSCs). 
Protein extracts were evaluated immediately after miR-203 exposure, to detect the 
modulation of Dnmt3a/b protein levels. Vinculin levels are included as loading control. 
 
Figure EV5. Genome-wide methylation of iPSCs or embryoid bodies after 
transient exposure to miR-203.  
A, Expression levels, as determined by quantitative PCR, of miR-203, and transcripts 
for the DNA methyltransferases Dnmt1, Dnmt3a, Dnmt3b, Dnmt3a2 and Dnmt3l, or 
pluripotency (Dazl) and differentiation (Gata6) markers. ColA1(miR-203/miR-203); 
Rosa26(rtTA/rtTA) iPSCs treated or not with doxycycline (Dox) and simultaneously 
transduced with Dnmt3a/b cDNAs or empty vector were used as shown in the schematic 
representation of the experimental design. The pink shadow indicates the time-lapse in 
which the cells were treated or not with Dox and transduced or not with Dnmt3a/b 
cDNAs. The green shadow indicates the differentiation process to embryoid bodies. 
Data are represented as mean of three technical replicates per experiment (n=2 
independent experiments).  
B, Experimental design used for the validation of methylation data in the indicated Elf5 
differentially methylated region (DMR).  
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C, DNA was isolated as indicated and sequenced after bisulfite modification. Eight to 
ten independent clones were sequenced per condition. Histograms show the percentage 
of DNA methylation at the Elf5 DMR in the different conditions.  
D, Experimental protocol followed to test DNA methylation rescue by miR-203-
resistant Dnmt3a/b cDNAs.  
E, The specific differentially methylated regions (DMR) at the Elf5 locus were analyzed 
by PCR amplification and sequencing of bisulphite-modified DNA. The quantification 
of methylated vs. unmethylated CpGs is shown in the histogram. 
 
Figure EV6. Improved cardiomyocyte differentiation and maturation after 
transient expression of miR-203.  
A, Representative immunofluorescence showing EdU (green) and nuclei (Hoechst, 
blue) staining of primary cardiomyocytes extracted at postnatal day 1 and transiently 
transfected with control or miR-203 mimics 24 hours after extraction. Pictures were 
taken three days after transfection. Scale bar, 60 μm. The histogram shows the 
percentage of EdU-positive cells at different days post-transfection. Data are mean ± 
s.d. (total number of cells counted is indicated in the figure; the dots represented in the 
bars correspond to n=2 independent experiments, with 5 and 4 different replicates, 
respectively.  
B, RNA expression as determined by quantitative PCR of miR-203 (24 hours after 
transfection) and Ccnb1, Myh6 and Myh7 transcripts (5 days after transfection). The 
Myh6/Myh7 ratio is calculated as an indicator of cardiomyocyte maturation. Data are 
mean ± s.d. (the dots represented in the bars correspond to n=3 independent 
experiments, with 2 replicates each).  
C, Representative immunofluorescence showing phospho-Histone 3 (Ser-10; pH3) in 
green, cardiac Troponin T (cTnT) in red and Hoechst for nuclei staining in blue, in 
primary cardiomyocytes extracted at postnatal day 1 and transiently transfected with 
control or miR-203 mimics 24h after extraction. Images were taken three days after 
transfection. Scale bars, 64 μm. White arrows point to cardiomyocytes positive for pH3. 
Yellow arrows point to cells positive for pH3 but not properly differentiated to 
cardiomyocytes, according to cardiac Troponin T staining. Middle histogram shows the 
proliferation rate measured as the percentage of pH3 positive cells respect to the total 
number of cTnT positive cells at day 3 post-transfection. Data are mean ± s.d. Total 
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number of cells counted is indicated in the figure; the dots represented in the bars 
correspond to n=2 independent experiments, with 8 different replicates each).The plot 
on the right shows the total number of cells at day 3 post-transfection. Data are mean ± 
s.d . The dots represented in the bars correspond to n=2 independent experiments with 5 
replicates each. 
D, mRNA levels as determined by quantitative PCR of the indicated transcripts at 
different time points before and during cardiomyocyte differentiation. iPSCs were 
transfected either with control mimics or miR-203 mimics, maintained during 15 days 
in culture and then differentiated in vitro. Data are mean ± s.d. The dots represented in 
the bars correspond to n=2 independent experiments, with 3 replicates each. 
E, mRNA levels of the indicated transcripts at different time points during 
cardiomyocyte differentiation. Data are mean ± s.d. The dots represented in the bars 
correspond to n=2 independent experiments, with 3 replicates each. 
Data information: In A-E data, *P<0.05, **P<0.01 (Student´s t-test). 
 
 
Movie EV1: Embryoid bodies derived from miiPSCs express markers from the 
three germ layers. Tridimensional organization of the embryoid bodies derived from 
miR-203-exposed iPSCs (miiPSCs), expressing markers from the three germ layers: 
primitive endoderm (Gata4; red), mesoderm (Cd34; green) and ectoderm (Pax6; blue). 
See Figure 1, EV1 and Appendix Figure S1 for more information. 
 
Movie EV2: Cardiomyocytes beating, differentiated from control iPSCs exposed to 
control mimics. Mouse iPSCs were transiently transfected with control mimics and 15 
days later they were differentiated into cardiomyocytes using specific media and culture 
conditions. See Figure 6 and Figure EV6 for more information. 
 
Movie EV3: Cardiomyocytes beating, differentiated from miiPSCs exposed to 
miR-203 mimics. Mouse iPSCs were transiently transfected with miR-203 mimics and 
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15 days later they were differentiated into cardiomyocytes using specific media and 
culture conditions. See Figure 6 and Figure EV6 for more information. 
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Cells Nº clones Mice inoculated Mice with E-Ls %
iPSC 8 8 0 0
iv iPSC 9 9 1 11
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